| Trial ID: | L5891 |
| Source ID: | NCT01570660
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Phielix et al.: Hepatic Fat Content and Adipokines
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Pioglitazone
|
| Outcome Measures: |
Primary: whole body insulin sensitivity, Participants underwent a two-step hyperinsulinemic euglycemic clamp to determine insulin sensitivity, expressed as rate of glucose disposal (Rd) in mg/kg/min., within a minimal of 1 week before the start of the 12 weeks pioglitazone or glimepiride treatment and after the last day of the treatment period. | Secondary: intrahepatocellular lipid content, Liver proton-magnetic resonance spectroscopy was applied to determine liver fat (HCL) in % (relative to the water peak)., within a minimal of 1 week before the start of the 12 weeks pioglitazone or glimepiride treatment and after the last day of the treatment period.
|
| Sponsor/Collaborators: |
Sponsor: German Diabetes Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2002-02
|
| Completion Date: |
2012-03
|
| Results First Posted: |
|
| Last Update Posted: |
2012-04-04
|
| Locations: |
Medical University of Vienna, Vienna, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT01570660
|
